🚨 FIRST ROUND OF ABSTRACT SUBMISSION CLOSES VERY SOON! 🚨 CVS 2027

The 2nd Edition of the International Conference on Cardiology and Cardiovascular Science will be held on March 22–24, 2027, in Singapore and Online, bringing together researchers, clinicians, cardiologists, healthcare professionals, scientists, academics, and industry experts from around the world.

🚨 First Round of Abstract Submission Closes Very Soon!

Researchers and professionals are invited to submit their original research, recent findings, clinical experiences, innovations, and scientific contributions for presentation at the conference.

Key scientific areas include:

• Cardiovascular Science and Medicine
• Cardiovascular Diseases and Disorders
• Pathophysiology of Cardiovascular Diseases
• Hypertension and Vascular Disorders
• Detection, Diagnosis, and Imaging
• Cardiovascular Disease Treatment and Therapeutic Approaches
• Cardiovascular Surgery and Interventional Cardiology
• Causes, Prevention and Lifestyle Modifications
• Clinical Trials and Drug Development
• Case Reports and Clinical Case Studies
• Public Health, Global Cardiology and Epidemiology
• Genetics and Epigenetics in Cardiology

🌍 Why Submit Your Abstract?

Submitting your research provides an opportunity to:

✅ Present your work to an international scientific audience
✅ Exchange knowledge with global experts
✅ Discover the latest developments in cardiovascular science
✅ Build professional and research collaborations
✅ Gain international exposure for your research

Don't wait until the deadline approaches. Prepare your abstract and submit it for consideration in the first round.

📅 March 22–24, 2027
📍 Singapore & Online

📧 Email: cardiology@mathewsconference.com
🌐 Web: cardiology.mathewsconferences.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377-0967

Submit Your Research | Share Your Innovations | Get Global Recognition

#CardiologyConference2027 #AbstractSubmission #CardiovascularScience #CardiologyResearch #MedicalConference #CallForAbstracts

Early Registration for CVS-2027 Closes Very Soon!

The 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027) is coming to Singapore & Online, and early registration closes very soon!

📅 March 22–24, 2027
📍 Singapore & Online

⏰ Register Early | Avail Special Rates | Secure Your Spot

CVS-2027 offers an international platform to connect with leading professionals, exchange research insights, explore emerging developments, and expand your professional network in the field of cardiology and cardiovascular science.

🌍 Why Register Early?

🔹 Network with Global Experts
Connect with cardiologists, researchers, clinicians, scientists, and healthcare professionals from around the world.

🔹 Gain Latest Research Insights
Explore emerging discoveries, innovative approaches, and advances in cardiovascular science and medicine.

🔹 Expand Your Professional Connections
Build meaningful collaborations and strengthen your international professional network.

📢 Don't wait until the last moment! Secure your participation and take advantage of the available special early registration rates.

🌐 Website: https://cardiology.miconferences.com/
📧 Email: cardiology@mathewsconference.com
📞 Phone: +1 (312) 462-4448
📱 WhatsApp: +1 (424) 377-0967
Register: https://cardiology.miconferences.com/register

Be part of the 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027) and connect with the global cardiovascular community!

#CVS2027 #Cardiology #CardiovascularScience #CardiologyConference #CardiovascularMedicine #CardiovascularResearch #HeartHealth #MedicalConference #HealthcareProfessionals #CardiologyResearch #EarlyRegistration #SingaporeConference #OnlineConference #GlobalHealth

CVS-2027 | 2nd Edition of International Conference on Cardiology and Cardiovascular Science

The future of cardiovascular medicine is shaped by scientific innovation, clinical discoveries, collaboration, and the exchange of knowledge. The 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027) invites the global cardiovascular community to come together for three days of scientific discussion and professional networking.

📅 March 22–24, 2027
📍 Singapore & Online

CVS-2027 provides an international platform for cardiologists, cardiovascular scientists, physicians, researchers, surgeons, healthcare professionals, academicians, and industry experts to present their work and discuss the latest developments in cardiovascular science and medicine.

🔬 Key Scientific Topics

The conference will cover a broad range of cardiovascular topics, including:

❤️ Cardiovascular Science and Medicine
❤️ Cardiovascular Diseases and Disorders
❤️ Pathophysiology of Cardiovascular Diseases
❤️ Hypertension and Vascular Disorders
❤️ Detection, Diagnosis, and Imaging
❤️ Cardiovascular Diseases Treatment and Therapeutic Approaches

🌍 Be Part of the Global Cardiovascular Community

CVS-2027 is an opportunity to:

🔹 Learn about the latest advances in cardiovascular science
🔹 Exchange knowledge with international experts
🔹 Present research and clinical findings
🔹 Discuss innovative approaches to cardiovascular disease prevention and treatment
🔹 Develop international scientific collaborations
🔹 Connect with professionals working across different areas of cardiology

Whether attending in person in Singapore or online, participants can engage in meaningful scientific discussions and explore the innovations shaping the future of cardiovascular healthcare.

📢 Join CVS-2027

Take part in the 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027) and help advance global conversations in cardiology and cardiovascular medicine.

🌐 https://cardiology.miconferences.com/
📧 Email: cardiology@mathewsconference.com
📞 Phone: +1 (312) 462-4448
📱 WhatsApp: +1 (424) 377-0967

#CVS2027 #Cardiology #CardiovascularScience #CardiovascularMedicine #CardiologyConference #HeartDisease #CardiovascularResearch #InterventionalCardiology #CardiacSurgery #Hypertension #HeartHealth #MedicalResearch #Healthcare #MedicalConference

CVS-2027 to Feature Presentation on Mechanical Circulatory Support and Transplantation

 The 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027) will feature an important scientific presentation addressing advanced treatment strategies for adults with congenital heart disease.

Massimo Griselli, from Rikshospitalet University Hospital, Norway, will deliver an Oral Presentation (Virtual) titled:

“Mechanical circulatory support and transplantation in adult congenital heart diseases”

The presentation will explore the growing importance of advanced cardiovascular therapies for adults with congenital heart disease who develop severe or end-stage heart failure.

With improvements in congenital heart disease care allowing more patients to reach adulthood, the management of complex cardiovascular conditions in this population continues to present significant clinical challenges. Mechanical circulatory support and transplantation represent important options for selected patients with advanced heart failure.

The presentation will highlight areas including:

• Mechanical circulatory support for adults with congenital heart disease
• Advanced heart failure and transplantation
• Challenges associated with complex congenital cardiac anatomy
• Multidisciplinary approaches to patient management
• Emerging developments in cardiovascular treatment
• Future directions in adult congenital heart disease care

The session will form part of the scientific program of CVS-2027, bringing together an international community of cardiologists, cardiovascular scientists, physicians, researchers, surgeons, and healthcare professionals.

Conference Information

Event: 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027)
Date: March 22–24, 2027
Location: Singapore & Online
Website: https://cardiology.miconferences.com/
Abstract Submission: https://cardiology.miconferences.com/abstract-submission
Registration: https://cardiology.miconferences.com/register

Be part of global scientific discussions on cardiology, cardiovascular science, congenital heart disease, heart failure, transplantation, and innovative cardiovascular therapies.

#CVS2027 #CardiologyConference #CardiovascularScience #Cardiology #CongenitalHeartDisease #AdultCongenitalHeartDisease #HeartFailure #HeartTransplantation #MechanicalCirculatorySupport #CardiovascularResearch #CardiovascularMedicine

🌍 Explore Highlights from Our Previous Conferences!

At Mathews International Conferences, we bring together researchers, healthcare professionals, scientists, academics, and industry experts to share knowledge and advance scientific collaboration.

🎥 Take a look at highlights from our previous conferences and stay connected with our scientific community.

▶️ Watch & Subscribe to our YouTube Channel: https://www.youtube.com/@MathewsInternationalLLC

❤️ Join CVS 2027!

We are pleased to invite you to the 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS 2027), scheduled for March 22–24, 2027, in Singapore & Online.

The conference provides an opportunity to present your research, exchange ideas with international experts, discover emerging developments in cardiology and cardiovascular science, and build professional collaborations.

🌐 Conference Website: https://cardiology.miconferences.com/

Be part of the conversation and contribute to the future of Cardiology and Cardiovascular Science.

#CVS2027 #CardiologyConference #CardiovascularScience #MedicalResearch #HealthcareProfessionals #ScientificConference #InternationalConference #MathewsInternationalConferences

Chronic Kidney Disease: Looking Beyond Diabetes | CVS-2027

 Chronic kidney disease (CKD) is a growing global health challenge and remains significantly underdiagnosed and undertreated. At the 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027), Dr. Osama Elmaraghi of Elite Hospital, Egypt, will present an insightful scientific session titled “Chronic kidney Disease: Looking Beyond Diabetes.”

The presentation will explore why CKD deserves greater attention beyond its well-established association with diabetes and cardiovascular disease. With CKD affecting hundreds of millions of people worldwide, early recognition and timely intervention are essential to reducing kidney failure and cardiovascular complications.

🔬 Key Presentation Highlights

🔹 Early Detection: Understanding how CKD can be identified before significant progression occurs.
🔹 CKD Staging: Reviewing the different stages of chronic kidney disease and appropriate clinical management.
🔹 Diabetic & Non-Diabetic CKD: Exploring kidney disease management in both diabetic and non-diabetic populations.
🔹 SGLT2 Inhibitors: Discussing evidence surrounding therapies such as empagliflozin and dapagliflozin and their kidney and cardiovascular benefits.
🔹 Cardio-Renal Protection: Examining how appropriate CKD treatment can help reduce cardiovascular complications and kidney failure.
🔹 Clinical Guidelines: Highlighting contemporary recommendations, including the 2026 ADA Guidelines and ADA-KDIGO consensus recommendations.

Dr. Osama Elmaraghi is a senior consultant in diabetes and an experienced researcher, author, speaker, and contributor to international scientific and medical forums.

🌍 Join CVS-2027

The 2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS-2027) will bring together cardiologists, cardiovascular researchers, physicians, healthcare professionals, and industry experts from around the world to discuss emerging developments in cardiovascular medicine.

📅 March 22–24, 2027
📍 Singapore & Online
🎓 15+ CPD Credits
🫀 Theme: Cardiology at the Crossroads of Discovery and Healing
🔗 Presentation: Chronic kidney Disease: Looking Beyond Diabetes
🌐 Conference Website: CVS-2027 Official Website

#CVS2027 #CardiologyConference #CardiovascularScience #ChronicKidneyDisease #CKD #Diabetes #CardiorenalHealth #SGLT2Inhibitors #KidneyDisease #Cardiology #Healthcare #MedicalResearch #CPD #SingaporeConference

Cardiovascular Benefits of GLP-1 RAs | CVS-2027

 Cardiovascular protection has become an increasingly important consideration in the management of metabolic and cardiovascular disease. At the 2nd Edition of International Conference on Cardiology and Cardiovascular Science, Dr. Manjula M.J. of Rajarajeswari Medical College and Hospital, India, will present her research titled “Cardiovascular efficacy of GLP-1 receptor agonists: A systematic review and meta-analysis.”

Her systematic review and meta-analysis evaluates the cardiovascular effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), examining evidence from major cardiovascular outcome trials and comparing their effects with SGLT2 inhibitors.

Key Research Highlights

The analysis included nine completed cardiovascular outcome trials involving 77,684 randomized participants. The findings demonstrated a significant reduction in three-point major adverse cardiovascular events (MACE) among patients receiving GLP-1 receptor agonists compared with placebo.

The pooled analysis reported a 15% reduction in three-point MACE, while additional evidence indicated reductions in cardiovascular death, non-fatal stroke, heart failure hospitalization, all-cause mortality, and composite kidney outcomes.

An important finding was the variation in heart-failure outcomes according to baseline heart-failure status. The analysis identified a significant benefit for the composite of heart-failure hospitalization or cardiovascular death among patients without a previous history of heart failure, while the effect was not statistically significant among those with baseline heart failure.

The research also compared GLP-1 receptor agonists with SGLT2 inhibitors through a network meta-analysis involving 14 trials and 117,633 patients. While both drug classes demonstrated comparable effects on MACE reduction, SGLT2 inhibitors showed greater benefits for heart-failure hospitalization and renal outcomes.

About Dr. Manjula M.J.

Dr. Manjula M.J., MBBS, MD, is a medical academician, researcher, and educator at Rajarajeswari Medical College and Hospital, India. Her professional interests include clinical research, medical education, evidence-based medicine, clinical data analysis, scientific writing, and healthcare research.

Her presentation contributes valuable evidence to ongoing discussions surrounding cardiometabolic therapies and the evolving role of GLP-1 receptor agonists in cardiovascular care.

Join the Conference

The 2nd Edition of International Conference on Cardiology and Cardiovascular Science will take place on March 22–24, 2027, in Singapore and Online. The hybrid event brings together cardiologists, cardiovascular researchers, clinicians, healthcare professionals, and industry experts to discuss advances in cardiovascular medicine and innovative approaches to improving heart health.

The conference is also a CPD Accredited Event, offering 15+ CPD credits to participants.

🌐 Conference Website: https://cardiology.miconferences.com/
📅 March 22–24, 2027
📍 Singapore & Online

#Cardiology #CardiovascularScience #GLP1 #GLP1ReceptorAgonists #CardiovascularHealth #HeartHealth #MACE #SGLT2Inhibitors #ClinicalResearch #MedicalResearch #CardiologyConference #CVS2027 #HeartDisease #DiabetesAndCardiovascularDisease #CardiovascularResearch